Fairvalue-Calculator Fairvalue-Calculator
EN DE

Crystalvue Medical Corporation (6527) Fair Value & Analysis

Healthcare · TW · Market cap 1.8B TWD

Price73.30 TWD
Fair Value103.03 TWD
Upside+40.6%
Quality95/100
Evidence: High Range 72.12 TWD – 133.94 TWD

Fair value as of: Jun 24, 2026

Analysis

Crystalvue Medical Corporation (6527) currently trades at 73.30 TWD, while our model-based Fair Value estimate is 103.03 TWD — implying the stock looks roughly 40.6% undervalued today. We read business quality at 95/100 (high quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

About the company

Crystalvue Medical Corporation manufactures and sells medical devices worldwide. The company offers optical coherence tomography, retinal cameras, tonometers, lens edgers, and gastroenterology supplies, as well as ODM/OEM services for automated nucleic acid extraction instrument and PCR system. It also sells minimal invasive endoscopic instrument supplies. The company was founded in 2009 and is based in Taoyuan City, Taiwan.

Open the full interactive analysis →

Similar stocks

Intuitive Surgical, Inc (ISRG) -61% EssilorLuxottica Société anonyme (ESLOF) -44% HOYA Corporation (HOCPY) -42% Medline Inc (MDLN) -5% Becton, Dickinson and Company (BDX) -16% Alcon Inc (ALC) -44%

Frequently asked questions

Is Crystalvue Medical Corporation (6527) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 103.03 TWD versus a price of 73.30 TWD — about +41% (undervalued). Model-based estimate, not financial advice.
What is the fair value of 6527?
Our 21-model fair value for Crystalvue Medical Corporation is 103.03 TWD (as of Jun 24, 2026), built from audited fundamentals. The current price is 73.30 TWD.
What is the quality score of 6527?
Crystalvue Medical Corporation has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.